Abstract
Post-hoc Analysis of the Effects of Dose Reductions of Concomitant Clobazam in a Phase 3, Open-Label Study of Cenobamate for the Treatment of Uncontrolled Focal Seizures (1851)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have